Arrhythmia Research Technology, Inc (HRT) - NYSEMKT
  • Thu, May 12, 5:32 PM
    • Arrhythmia Research (NYSEMKT:HRT): Q1 EPS of -$0.14
    • Revenue of $4.98M (-15.0% Y/Y)
    • Press Release
    | Thu, May 12, 5:32 PM
  • Thu, Mar. 10, 4:50 PM
    • Arrhythmia Research (NYSEMKT:HRT): Q4 EPS of -$0.14
    • Revenue of $4.75M (-17.2% Y/Y)
    • Press Release
    | Thu, Mar. 10, 4:50 PM
  • Nov. 12, 2015, 7:29 AM
    • Arrhythmia Research (NYSEMKT:HRT): Q3 EPS of -$0.10
    • Revenue of $5.23M (-13.6% Y/Y)
    | Nov. 12, 2015, 7:29 AM
  • Aug. 13, 2015, 5:19 PM
    • Arrhythmia Research (NYSEMKT:HRT): Q2 EPS of $0.04
    • Revenue of $5.66M (-9.4% Y/Y)
    | Aug. 13, 2015, 5:19 PM
  • May 13, 2015, 4:59 PM
    • Arrhythmia Research (NYSEMKT:HRT): Q1 EPS of -$0.09
    • Revenue of $5.86M (-2.8% Y/Y)
    | May 13, 2015, 4:59 PM
  • Mar. 20, 2015, 7:33 AM
    • Arrhythmia Research Technology (HRT -0.4%) Q4 results: Revenues: $5.7M (-6.6%); COGS: $4.7M (-7.8%); Operating Expense: $0.9M (-10.0%); Operating Income: $0.1M (+433.3%); Net Income: $32.4K (+143.6%); EPS: $0.01 (+133.3%).
    • FY2014 results: Revenues: $24.1M (+13.1%); COGS: $19.4M (+6.0%); Operating Expense: $3.7M (-7.5%); Operating Income: $0.9M (+190.0%); Net Income: $0.7M (+120.0%); EPS: $0.23 (+117.7%); Quick Assets: $0.2M (-71.4%).
    • No guidance given.
    | Mar. 20, 2015, 7:33 AM
  • Mar. 20, 2015, 7:10 AM
    • Arrhythmia Research (NYSEMKT:HRT): Q4 EPS of $0.01
    • Revenue of $5.74M (-5.7% Y/Y)
    | Mar. 20, 2015, 7:10 AM
  • Nov. 12, 2014, 7:53 AM
    • Arrhythmia Research (NYSEMKT:HRT): Q3 EPS of $0.05.
    • Revenue of $6M (+27.7% Y/Y).
    | Nov. 12, 2014, 7:53 AM
  • Aug. 8, 2014, 7:48 AM
    • Arrhythmia Research Technology (NYSEMKT:HRT) Q2 results: Revenues: $6.3M (+28.8%); Gross Profit: $1.1M (+103.3%); Operating Expenses: $869.3K (-2.7%); Operating Income: $264.7K (+178.8%); Net Income: $240.5K (+108.3%); EPS: $0.09 (+108.5%); Quick Assets: $232.0K (-69.1%); CF Ops (1H): $829.7K (+999%).
    • No guidance given.
    | Aug. 8, 2014, 7:48 AM
  • May 9, 2014, 7:58 AM
    • Arrhythmia Research Technology (HRT): Q1 EPS of $0.09.
    • Revenue of $6.02M (+6.9% Y/Y).
    | May 9, 2014, 7:58 AM
  • Nov. 20, 2013, 12:02 AM
    • Arrhythmia Research Technology (HRT): Q3 EPS of -$0.21.
    • Revenue of $4.7M (-4.7% Y/Y). (PR)
    | Nov. 20, 2013, 12:02 AM
  • Oct. 8, 2013, 8:45 AM
    • Arrhythmia Research Technology (HRT): Q2 EPS of -$1.06.
    • Revenue of $4.88M beats by $0.08M. (PR)
    | Oct. 8, 2013, 8:45 AM
  • Aug. 20, 2013, 1:51 PM
    • Arrhythmia Research Technology (HRT) says it didn't file its quarterly earnings report by the August 19 due date because of an ongoing review into the valuation of deferred tax assets.
    • On a preliminary basis, the company said it expects to report Q2 revenue rose 1.9% to $4.88M from a revised $4.79M a year ago.
    • It also sees its net loss for the three months ended in June narrowing to $328,022 from a $1.04M loss in the year-ago period.
    • The stock was halted earlier, but has since resumed trading.
    | Aug. 20, 2013, 1:51 PM
Company Description
Arrhythmia Research Technology, Inc. is a diversified contract manufacturing organization that produces engineered, medical device technologies requiring precision machining and injection molding. The Company also manufactures components, devices and equipment for military, law enforcement,... More
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States